The global Cardiometabolic Drugs Market is anticipated to reach US$ 50 billion by 2021. Cardiometabolic drug sales are estimated to hit US$ 70 billion by 2032, growing at a CAGR of 4% to 5% between 2022 and 2032. The market for cardiometabolic pharmaceuticals is predicted to exceed US$ 55 billion by 2022, owing to an …
Continue reading “Cardiometabolic Drugs Market are estimated to hit US$ 70 Bn by 2032 | FMI”